Denis I. Zrelkin

Gamalei Institute of Epidemiology and Microbiology — Russia

Medicine · Health Sciences

5h-index3.0kcitations20works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(8), Virus-based gene therapy research(7), Viral gastroenteritis research and epidemiology(7), Animal Virus Infections Studies(5), COVID-19 Clinical Research Studies(4)

Publications20 total

Adenoviral Vectors Expressing Optimized preM/E Genes of WNV Deliver Long-Term Protection Against Lethal West Nile Virus Challenge
Vaccines·2025Open Access
Single-Dose Intranasal or Intramuscular Administration of Simian Adenovirus-Based H1N1 Vaccine Induces a Robust Humoral Response and Complete Protection in Mice
Viruses·2025· 2 citedOpen Access
Study of the protective properties of immunodominant proteins of orthopoxviruses in various methods of immunization
Journal of microbiology epidemiology immunobiology·2025Open Access
Study of the immunological efficacy and safety of a candidate vaccine against Lassa hemorrhagic fever
Medical Immunology (Russia)·2025· 1 citedOpen Access
Seroprevalence and cross-reactivity of neutralizing antibodies to six types of adenoviruses
2024· 1 citedOpen Access
Protective potential of structural proteins of the SARS-CoV-2 virus in protecting against COVID-19
Journal of microbiology epidemiology immunobiology·2024Open Access
DETERMINATION OF THRESHOLD VALUE OF PROTECTIVE LEVEL OF ANTIBODIES TO ONE OF MEMBERS OF ORTHOPOXVIRUS GENUS
2024· 1 citedOpen Access
A Study of the Influence of Nucleotide Sequence Optimization of the Target Gene on the Immunogenicity of a Recombinant Adenovirus Vector
Molecular Genetics Microbiology and Virology·2024
<i>In vitro</i> and <i>in vivo</i> tropism and biodistribution of recombinant simian adenovirus type 25
Journal of microbiology epidemiology immunobiology·2024· 2 citedOpen Access
Immunogenicity and Protectivity of Sputnik V Vaccine in hACE2-Transgenic Mice against Homologous and Heterologous SARS-CoV-2 Lineages Including Far-Distanced Omicron BA.5
Vaccines·2024· 1 citedOpen Access
Comprehensive evaluation of immunological activity of recombinant AD26 and AD5 expressing S protein gene of the SARS-COV-2 virus
Immunopathology Allergology Infectology·2024Open Access
P213 Determination of metallo-β-lactamase genes Pseudomonas aeruginosa isolated from chronic lung infection in CF patients
Journal of Cystic Fibrosis·2024
Study of the influence of nucleotide sequence optimization of the target gene on the immunogenicity of a recombinant adenovirus vector
Molecular Genetics Microbiology and Virology (Russian)·2024
Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study
Frontiers in Immunology·2023· 15 citedOpen Access
Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus
Frontiers in Immunology·2022· 13 citedOpen Access
An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus infection in healthy adults
The Lancet Regional Health - Europe·2021· 71 citedOpen Access
Review of candidate vaccines for the prevention of Lassa fever
Problems of Virology·2021· 1 citedOpen Access
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
The Lancet·2021· 1.8k citedOpen Access
An Open, Non-Randomised, 1/2 Phase Study on the Safety, Tolerability, and Immunogenicity of Single Dose 'Sputnik Light' Vaccine for Prevention of Coronavirus Infection in Healthy Adults
SSRN Electronic Journal·2021· 4 citedOpen Access
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
The Lancet·2020· 1.1k citedOpen Access

Frequent Co-authors

Olga V. Zubkova(17), Dmitry V. Shcheblyakov(16), Olga Popova(16), Denis Y. Logunov(15), Inna V. Dolzhikova(15), Gintsburg Al(15), Tatiana A. Ozharovskaia(15), Daria M. Grousova(11), Daria V. Voronina(11), Amir I. Tukhvatulin(9), Anna V. Kovyrshina(9), Polina P. Goldovskaya(9), Boris S. Naroditsky(8), Alina S. Dzharullaeva(7), Alina S. Erokhova(6), I. A. FAVORSKAYA(6), А. С. Семихин(6), Vladimir А. Gushchin(6), Nadezhda L. Lubenets(5), А Г Ботиков(5)